ACE2 and Alzheimer disease: On the other hand, SARS-CoV-2 infection might lead to a higher risk of AD in the future through inducing neuroinflammation, overactivation of the classical RAS, blood–brain barrier damage, ischemic within white matter, and the downregulation of ACE2 (Miners et al., 2020).